Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Pharmaceutical Insights: Sintilimab's R&D Progress and its Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Sintilimab, the Mechanism of Action for Sintilimab, and the drug target R&D trends for Sintilimab.
"What" Series
2 min read
What is Protocol in Life Sciences?
28 September 2023
A protocol outlines the experiment's context, theory, and intent, its design, methodology, and structure including statistical considerations, and the conditions for execution and completion.
Drug Insights
4 min read
Exploring Sargramostim's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Sargramostim, the Mechanism of Action for Sargramostim, and the drug target R&D trends for Sargramostim.
Latest Hotspot
3 min read
The Phase 3 TROPION-Breast01 trial showed Datopotamab Deruxtecan significantly improved progression-free survival in patients with HR positive, HER2 low/negative breast cancer
28 September 2023
The Phase 3 TROPION-Breast01 trial showed that Datopotamab Deruxtecan significantly improved progression-free survival for patients with HR positive, HER2 low or negative breast cancer.
Drug Insights
4 min read
Decoding Rocuronium Bromide: A Comprehensive Study of its R&D Trends
28 September 2023
This article summarized the latest R&D progress of Rocuronium Bromide, the Mechanism of Action for Rocuronium Bromide, and the drug target R&D trends for Rocuronium Bromide.
"What" Series
2 min read
What is DSMB?
28 September 2023
DSMB stands for Data Safety and Monitoring Board, an independent expert group established to safeguard the rights and needs of infants and young children participating in Phase III clinical trials.
Drug Insights
4 min read
Deep Scientific Insights on Ripretinib's R&D Progress, Mechanism of Action, and Drug Target
28 September 2023
This article summarized the latest R&D progress of Ripretinib, the Mechanism of Action for Ripretinib, and the drug target R&D trends for Ripretinib.
Latest Hotspot
3 min read
Antengene Declares Phase I Trial for ATG-031, an Anti-CD24 Monoclonal Antibody
28 September 2023
Antengene Corp Ltd obtained approval from University of Texas MD Anderson Cancer Center's Institutional Review Board for a Phase I trial of its prime anti-CD24 antibody, ATG-031, focusing on advanced hematology and oncology solutions.
Drug Insights
4 min read
An In-depth Analysis of Propantheline Bromide's R&D Progress and Mechanism of Action on Drug Target
28 September 2023
This article summarized the latest R&D progress of Propantheline Bromide, the Mechanism of Action for Propantheline Bromide, and the drug target R&D trends for Propantheline Bromide.
"What" Series
2 min read
What is MAH in Life Sciences?
28 September 2023
The full name is Marketing Authorization Holder. This typically refers to entities such as drug development institutions that possess drug technology, scientific researchers, and pharmaceutical manufacturing enterprises.
Drug Insights
4 min read
Pholcodine: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
28 September 2023
This article summarized the latest R&D progress of Pholcodine, the mechanism of action for Pholcodine, and the drug target R&D trends for Pholcodine.
Latest Hotspot
3 min read
Alvotech Gives U.S. Regulatory Progress Report on AVT02, a Humira® (adalimumab) Interchangeable Biosimilar Candidate with High Concentration
28 September 2023
Alvotech declared today that the U.S. FDA has agreed to Alvotech's revised BLA for AVT02.